Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Horvath

Showing results (201-210 of 279) with videos related to

Pageof 28
Sort By:
Molecular & Cellular Proteomics : MCP|June 5, 2016
Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine ProfilingEmily S Humphrey, Shih-Ping Su, Adnan M Nagrial, et al.
Journal of Molecular Neuroscience : MN|May 8, 2010
Changes in the expression of pituitary adenylate cyclase-activating polypeptide in the human placenta during pregnancy and its effects on the survival of JAR choriocarcinoma cellsR Brubel, A Boronkai, D Reglodi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 8, 2013
Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridizationChristina I Selinger, Toni-Maree Rogers, Prudence A Russell, et al.
Cancer Research Communications|March 6, 2026
A phase I study of hydroxychloroquine and suba-itraconazole in men with biochemical relapse of prostate cancer (HITMAN-PC): dose escalation resultsBarak Talmor, Stefano Marastoni, Brandon Lau, et al.
Molecular Systems Biology|March 7, 2022
An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and in silico simulations of enteric hyperoxaluriaDavid Lubkowicz, Nicholas G Horvath, Michael J James, et al.
British Journal of Cancer|August 22, 2014
Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancerK L Mahon, W Qu, J Devaney, et al.
Lung Cancer (Amsterdam, Netherlands)|May 31, 2015
PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinomaWendy A Cooper, Thang Tran, Ricardo E Vilain, et al.
Scientific Reports|May 20, 2018
MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancerHui-Ming Lin, Iva Nikolic, Jessica Yang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 5, 2008
Immunohistochemical level of unsulfated chondroitin disaccharides in the cancer stroma is an independent predictor of prostate cancer relapseAndrew J Sakko, Miriam S Butler, Sharon Byers, et al.
The Prostate|January 10, 2018
Effect of FAK inhibitor VS-6063 (defactinib) on docetaxel efficacy in prostate cancerHui-Ming Lin, Brian Y Lee, Lesley Castillo, et al.
Pageof 28

Showing results (201-210 of 279) with videos related to

Sort By:
Pageof 28
Molecular & Cellular Proteomics : MCP|June 5, 2016
Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine ProfilingEmily S Humphrey, Shih-Ping Su, Adnan M Nagrial, et al.
Journal of Molecular Neuroscience : MN|May 8, 2010
Changes in the expression of pituitary adenylate cyclase-activating polypeptide in the human placenta during pregnancy and its effects on the survival of JAR choriocarcinoma cellsR Brubel, A Boronkai, D Reglodi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 8, 2013
Testing for ALK rearrangement in lung adenocarcinoma: a multicenter comparison of immunohistochemistry and fluorescent in situ hybridizationChristina I Selinger, Toni-Maree Rogers, Prudence A Russell, et al.
Cancer Research Communications|March 6, 2026
A phase I study of hydroxychloroquine and suba-itraconazole in men with biochemical relapse of prostate cancer (HITMAN-PC): dose escalation resultsBarak Talmor, Stefano Marastoni, Brandon Lau, et al.
Molecular Systems Biology|March 7, 2022
An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and in silico simulations of enteric hyperoxaluriaDavid Lubkowicz, Nicholas G Horvath, Michael J James, et al.
British Journal of Cancer|August 22, 2014
Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancerK L Mahon, W Qu, J Devaney, et al.
Lung Cancer (Amsterdam, Netherlands)|May 31, 2015
PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinomaWendy A Cooper, Thang Tran, Ricardo E Vilain, et al.
Scientific Reports|May 20, 2018
MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancerHui-Ming Lin, Iva Nikolic, Jessica Yang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 5, 2008
Immunohistochemical level of unsulfated chondroitin disaccharides in the cancer stroma is an independent predictor of prostate cancer relapseAndrew J Sakko, Miriam S Butler, Sharon Byers, et al.
The Prostate|January 10, 2018
Effect of FAK inhibitor VS-6063 (defactinib) on docetaxel efficacy in prostate cancerHui-Ming Lin, Brian Y Lee, Lesley Castillo, et al.
Pageof 28